Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 15 | $6.91 | $7.60 | $7.12 |
| Q2 2026 | 15 | $7.22 | $7.60 | $7.38 |
| Q3 2026 | 14 | $6.84 | $7.63 | $7.31 |
| Q4 2026 | 10 | $8.18 | $8.57 | $8.38 |
| Q1 2027 | 10 | $7.67 | $8.04 | $7.87 |
| Q2 2027 | 6 | $7.97 | $8.35 | $8.17 |
| Q3 2027 | 7 | $7.78 | $8.15 | $7.98 |
| Q4 2027 | 6 | $9.21 | $9.65 | $9.44 |
| Q1 2028 | 7 | $8.90 | $9.32 | $9.12 |
| Q2 2028 | 7 | $8.38 | $8.78 | $8.59 |
| Q3 2028 | 12 | $7.84 | $8.22 | $8.04 |
| Q4 2028 | 7 | $10.39 | $10.88 | $10.65 |
HCA Healthcare Inc last posted its earnings results on Friday, April 24th, 2026. The company reported $7.15 earnings per share for the quarter, topping analysts' consensus estimates of $7.12 by $0.03. The company had revenue of 19.11 B for the quarter and had revenue of 75.60 B for the year. HCA Healthcare Inc has generated $29 earnings per share over the last year ($28.38 diluted earnings per share) and currently has a price-to-earnings ratio of 14.26. HCA Healthcare Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/29/2026 | Q1 2026 | N/A | $7.15 | N/A | $19.09 B | $19.11 B |
| 02/10/2026 | Q4 2025 | N/A | $8.14 | N/A | $19.68 B | $19.51 B |
| 10/30/2025 | Q3 2025 | N/A | $7.05 | N/A | $18.60 B | $19.16 B |
| 08/04/2025 | Q2 2025 | N/A | $6.91 | N/A | $18.50 B | $18.61 B |
| 05/01/2025 | Q1 2025 | N/A | $6.52 | N/A | $18.26 B | $18.32 B |
| 02/13/2025 | Q4 2024 | N/A | $5.70 | N/A | $18.23 B | $18.29 B |
| 10/31/2024 | Q3 2024 | N/A | $4.94 | N/A | $17.54 B | $17.49 B |
| 07/29/2024 | Q2 2024 | N/A | $5.60 | N/A | $17.05 B | $17.49 B |
| 05/02/2024 | Q1 2024 | N/A | $6.04 | N/A | $16.81 B | $17.34 B |
| 02/16/2024 | Q4 2023 | N/A | $6.05 | N/A | N/A | $17.30 B |
| 11/16/2023 | Q3 2023 | N/A | $3.92 | N/A | N/A | $16.21 B |
| 08/02/2023 | Q2 2023 | N/A | $4.35 | N/A | N/A | $15.86 B |
| 04/27/2023 | Q1 2023 | N/A | $4.92 | N/A | N/A | $15.59 B |
| 02/17/2023 | Q4 2022 | N/A | $7.50 | N/A | N/A | $15.50 B |
| 11/01/2022 | Q3 2022 | N/A | $3.97 | N/A | N/A | $14.97 B |
| 08/01/2022 | Q2 2022 | N/A | $3.95 | N/A | N/A | $14.82 B |
| 05/03/2022 | Q1 2022 | N/A | $4.21 | N/A | N/A | $14.95 B |
| 02/18/2022 | Q4 2021 | N/A | $5.94 | N/A | N/A | $15.06 B |
| 11/01/2021 | Q3 2021 | N/A | $7.13 | N/A | N/A | $15.28 B |
| 08/02/2021 | Q2 2021 | N/A | $4.42 | N/A | N/A | $14.44 B |
In the previous quarter, HCA Healthcare Inc (:HCA) reported $7.15 earnings per share (EPS) to beat the analysts' consensus estimate of $7.12 by $0.03.
The conference call for HCA Healthcare Inc's latest earnings report can be listened to online.
The conference call transcript for HCA Healthcare Inc's latest earnings report can be read online.
HCA Healthcare Inc (:HCA) has a recorded annual revenue of $75.60 B.
HCA Healthcare Inc (:HCA) has a recorded net income of $6.78 B.HCA Healthcare Inc has generated $28.62 earnings per share over the last four quarters.
HCA Healthcare Inc (:HCA) has a price-to-earnings ratio of 14.26 and price/earnings-to-growth ratio is 0.5.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED